-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Profusa (NASDAQ:PFSA) shares moved upwards by 35.4% to $1.15 during Thursday's regular session.
  • Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 29.12% to $0.55. The company's market cap stands at $8.1 million.
  • Estrella Immunopharma (NASDAQ:ESLA) shares increased by 24.52% to $0.68. The market value of their outstanding shares is at $17.3 million.
  • Biohaven (NYSE:BHVN) shares rose 23.82% to $14.55. The market value of their outstanding shares is at $1.7 billion.
  • Korro Bio (NASDAQ:KRRO) stock moved upwards by 21.74% to $11.31. The market value of their outstanding shares is at $139.0 million.
  • MoonLake (NASDAQ:MLTX) stock increased by 17.08% to $12.47. The market value of their outstanding shares is at $878.3 million.

Losers

  • Pomdoctor (NASDAQ:POM) shares declined by 38.9% to $1.84 during Thursday's regular session. The market value of their outstanding shares is at $1.8 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock declined by 36.63% to $7.77. The market value of their outstanding shares is at $662.8 million.
  • Picard Medical (AMEX:PMI) shares declined by 22.07% to $7.5. The market value of their outstanding shares is at $21.5 million.
  • Moderna (NASDAQ:MRNA) shares fell 20.91% to $194.43. The market value of their outstanding shares is at $96.0 billion.
  • LeonaBio (NASDAQ:LONA) stock decreased by 14.64% to $4.84. The company's market cap stands at $49.6 million.
  • YD Bio (NASDAQ:YDES) stock declined by 14.22% to $4.95. The company's market cap stands at $413.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending